Brief: Infinity Pharmaceuticals Expects Net Loss For 2020 Between $40 Mln And $50 Mln
03/03/2020 21:18
March 3 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS REPORTS FULL YEAR 2019 FINANCIAL
RESULTS AND PROVIDES COMPANY UPDATE
* INFINITY PHARMACEUTICALS INC SAYS EXPECTS NET LOSS FOR
2020 TO
RANGE FROM $40 MILLION TO $50 MILLION
* INFINITY PHARMACEUTICALS - EXPECTS TO END 2020 WITH
YEAR-END
CASH, CASH EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES BALANCE
RANGING FROM $15 MILLION - $25 MILLION
Source text for Eikon: ID:nBw9s7yLta
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX